safingol has been researched along with Sarcoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Auzenne, E; Feig, B; Hu, M; Klostergaard, J; Leroux, ME; Pollock, RE | 1 |
Dyatlovitskaya, EV; Kandyba, AG; Kobliakov, VA; Kozlov, AM; Nagaev, IY; Shevchenko, VP | 1 |
2 other study(ies) available for safingol and Sarcoma
Article | Year |
---|---|
Cytotoxic effects of sphingolipids as single or multi-modality agents on human melanoma and soft tissue sarcoma in vitro.
Topics: Alkaloids; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzophenanthridines; Carboxylic Acids; Cell Survival; Ceramides; Dose-Response Relationship, Drug; Fumonisins; Histiocytoma, Benign Fibrous; Humans; Lung Neoplasms; Melanoma; Melphalan; Phenanthridines; Protein Kinase C; Sarcoma; Signal Transduction; Sphingosine; Time Factors; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1998 |
Dihydroceramide desaturase activity in tumors.
Topics: Animals; Carcinoma, Hepatocellular; Injections, Subcutaneous; Liver; Liver Neoplasms; Mice; Neoplasm Transplantation; Oxidoreductases; Rats; Sarcoma; Sphingosine | 2002 |